Physician profile
Ivonne E Smith
NPI 1609878941
$8,341.85
in general payments reported to CMS, 2019-2025
31 companies · $495 in 2025
The $495 reported for 2025 was more than what 80% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $500 · 2020: $308 · 2021: $435 · 2022: $659 · 2023: $673 · 2024: $5,272 · 2025: $495.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,500 · Food and Beverage: $1,530 · Travel and Lodging: $411.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,500.00 |
| Food and Beverage | $1,529.79 |
| Travel and Lodging | $410.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,105.99 | 2024-2025 | |
| Abbvie INC. | $863.05 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Astellas Pharma US INC | $232.30 | 2022-2025 | Veozah, Myrbetriq |
| Exeltis, USA INC. | $225.92 | 2019-2025 | Slynd |
| Sumitomo Pharma America, INC. | $192.68 | 2023-2024 | Myfembree |
| Medtronic, INC. | $175.98 | 2023-2025 | Venaseal, V-Loc 180 |
| Coopersurgical, INC. | $174.49 | 2019-2025 | Paragard T 380a, Paragard T 380a, Advincula Delineator Uterine Manipulator |
| Myovant Sciences INC. | $163.93 | 2021-2022 | |
| Agile Therapeutics, INC. | $151.90 | 2021-2023 | Twirla |
| Bayer Healthcare Pharmaceuticals INC. | $129.86 | 2019-2023 | |
| Hologic Sales and Service, LLC | $127.19 | 2019-2025 | Novasure, Fluent Fluid Management System, Acessa Provu System |
| Pfizer INC. | $91.06 | 2022-2024 | |
| Renovia INC | $82.49 | 2019-2020 | |
| Organon LLC | $62.02 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $61.45 | 2019-2023 | Gardasil 9 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aspira Women'S Health INC | $60.57 | 2022-2024 | Ova1 |
| Exact Sciences Corporation | $60.27 | 2023-2025 | Cologuard Collection Kit |
| Mayne Pharma Commercial LLC | $57.65 | 2023-2024 | |
| Mylan Pharmaceuticals INC. | $48.64 | 2019-2021 | |
| Sage Therapeutics, LLC | $46.36 | 2024-2025 | Zurzuvae |
| Medicem INC. | $34.22 | 2021-2022 | |
| Avion Pharmaceuticals | $28.87 | 2020-2021 | |
| Smith+Nephew, INC. | $28.60 | 2024 | Pico 7 |
| Allergan, INC. | $23.14 | 2019 | |
| Boston Scientific Corporation | $22.66 | 2023 | |
| Lupin INC. | $19.90 | 2019 | |
| Amneal Pharmaceuticals LLC | $16.48 | 2025 | Unithroid |
| Novo Nordisk INC | $14.64 | 2023 | Wegovy |
| Amgen INC. | $14.29 | 2023 | Prolia |
| Evofem Biosciences, INC. | $13.55 | 2020 | |
| Therapeuticsmd, INC. | $11.70 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ivonne Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.